5 Einträge gefunden

1. BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition.

   1. Duy, Cihangir
   2. Hurtz, Christian
   3. Shojaee, Seyedmehdi
   4. Cerchietti, Leandro
   5. Geng, Huimin
   6. Swaminathan, Srividya
   7. Klemm, Lars

   2011 - Forschungsinformationssystem des UKE
2. BCL6-mediated repression of p53 is critical for leukemia stem cell survival in chronic myeloid leukemia.

   1. Hurtz, Christian
   2. Hatzi, Katerina
   3. Cerchietti, Leandro
   4. Balabanov, Melanie
   5. Park, Eugene
   6. Kim, Yong-mi
   7. Herzog, Sebastian

   2011 - Forschungsinformationssystem des UKE
3. Abcg2 overexpression represents a novel mechanism for acquired resistance to the multi-kinase inhibitor Danusertib in BCR-ABL-positive cells in vitro.

   1. Balabanov, Stefan
   2. Gontarewicz, Artur
   3. von Amsberg, Gunhild
   4. Raddrizzani, Laura
   5. Balabanov, Melanie
   6. Bosotti, Roberta
   7. Moll, Jürgen

   2011 - Forschungsinformationssystem des UKE - frei zugänglich
4. Ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) is a potential tumour suppressor in prostate cancer and is frequently silenced by promoter methylation.

   1. Ummanni, Ramesh
   2. Jost, Edgar
   3. Balabanov, Melanie
   4. Lohmann, Frithjof
   5. Mundt, Frederike
   6. Barett, Christine
   7. Schlomm, Thorsten

   2011 - Forschungsinformationssystem des UKE - frei zugänglich
5. Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells.

   1. Brassat, Ute
   2. Balabanov, Stefan
   3. Bali, Daniel
   4. Dierlamm, Judith
   5. Balabanov, Melanie
   6. Hartmann, Ulrike
   7. Sirma, Hüseyin

   2011 - Forschungsinformationssystem des UKE